Improving Detection of CAD and Prognosis with PET/CT Quantitative Absolute Myocardial Blood Flow Measurements

[31] Dekemp RA(2021)Comparison of myocardial blood flow and flow reserve with dobutamine and dipyridamole stress using rubidium-82 positron emission tomography J Nucl Cardiol 28 34-447

[32] Harel F(2011)Comparison of the myocardial blood flow response to regadenoson and dipyridamole: a quantitative analysis in patients referred for clinical 82Rb myocardial perfusion PET Eur J Nucl Med Mol Imaging 38 1908-1210

[33] Pelletier-Galarneau M(2015)Regadenoson versus dipyridamole hyperemia for cardiac PET imaging JACC Cardiovasc Imaging 8 438-27

[34] Goudarzi B(2013)Added prognostic value of myocardial blood flow quantitation in rubidium-82 positron emission tomography imaging Eur Heart J Cardiovasc Imaging 14 1203-2224

[35] Johnson NP(2015)Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization Circulation 131 19-732

[36] Gould KL(2011)Improved cardiac risk assessment with noninvasive measures of coronary flow reserve Circulation 124 2215-156

[37] Farhad H(2011)Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging J Nucl Med 52 726-879

[38] Taqueti VR(2009)Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve J Am Coll Cardiol 54 150-219

[39] Murthy VL(2011)Myocardial perfusion reserve after a PET-driven revascularization procedure: a strong prognostic factor J Nucl Med 52 873-748

[40] Fukushima K(2009)Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease J Nucl Med 50 214-786

[31] Dekemp RA(2021)Comparison of myocardial blood flow and flow reserve with dobutamine and dipyridamole stress using rubidium-82 positron emission tomography J Nucl Cardiol 28 34-447

[32] Harel F(2011)Comparison of the myocardial blood flow response to regadenoson and dipyridamole: a quantitative analysis in patients referred for clinical 82Rb myocardial perfusion PET Eur J Nucl Med Mol Imaging 38 1908-1210

[33] Pelletier-Galarneau M(2015)Regadenoson versus dipyridamole hyperemia for cardiac PET imaging JACC Cardiovasc Imaging 8 438-27

[34] Goudarzi B(2013)Added prognostic value of myocardial blood flow quantitation in rubidium-82 positron emission tomography imaging Eur Heart J Cardiovasc Imaging 14 1203-2224

[35] Johnson NP(2015)Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization Circulation 131 19-732

[36] Gould KL(2011)Improved cardiac risk assessment with noninvasive measures of coronary flow reserve Circulation 124 2215-156

[37] Farhad H(2011)Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging J Nucl Med 52 726-879

[38] Taqueti VR(2009)Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve J Am Coll Cardiol 54 150-219

[39] Murthy VL(2011)Myocardial perfusion reserve after a PET-driven revascularization procedure: a strong prognostic factor J Nucl Med 52 873-748

[40] Fukushima K(2009)Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease J Nucl Med 50 214-786